Cardiology

Presented at ESC 2024, vutrisiran, an RNAi therapeutic, significantly reduced mortality and cardiovascular events in patients with ATTR-CM.

Integrating a polygenic score with clinical data improves predicting ascending aortic diameter and thoracic aortic events, outperforming traditional models.

Benzodiazepine usage has been associated with increased risk of coronary heart diseases heart failure, and cardiovascular death, according to recent research.

Researchers have determined that the benefit of bystander cardiopulmonary resuscitation on survival for out-of-hospital cardiac arrest is lowest in non-Hispanic Black individuals and women.

Ambient air pollution has been linked to an increased risk of all-cause death, hospital readmission, and burden of all-cause readmissions in patients with heart failure.

A multicentre study of 259 patients with prior CABG surgery found that post-PCI graft patency significantly predicts chronic total occlusion failure after PCI.

A new score to assess the risk of anthracycline-induced cardiovascular toxicity has been developed by researchers.

Wearable devices confirm digoxin is as effective as beta-blockers for heart rate control in atrial fibrillation patients.